Erste Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
TCM
ACM
CC
RCM
PBA
OM
WP
Erste Asset Management's EDIT Position: Q2 2026 in Review
Erste Asset Management opened a new position in Editas Medicine (EDIT) in Q2 2026: 230,000 shares worth $736K. The stake represents 0.01% of the portfolio and ranks #473 among its holdings. This is a return to the name: Erste Asset Management previously reported a position in EDIT as recently as Q3 2024.
Erste Asset Management first reported a position in EDIT in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.42M in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- Erste Asset Management held 230,000 shares of Editas Medicine worth $736K as of Q2 2026.
- Editas Medicine was a new Erste Asset Management position in Q2 2026.
- Editas Medicine made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #473 holding.
- Erste Asset Management first reported a position in Editas Medicine in Q4 2018 and has held it in 24 quarters since.
- Erste Asset Management's Editas Medicine position peaked at $1.42M in Q4 2020.
- 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.